Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3451 of 6351
-
Can extra coaching sessions curb teen suicide? new study says maybe.
Symptom relief CompletedSuicide is a leading cause of death and significant concerns for adolescents and young adults. Dialectical Behavior Therapy for Adolescents (DBT-A) is an evidence-based intervention that effectively reduces life-threatening behaviors. Limited research examines the impact of addin…
Sponsor: Compass Behavioral Health • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Hope for rare fat disorder: drug keeps working in Long-Term study
Disease control OngoingBackground: \- Partial lipodystrophy can cause high blood fat levels and resistance to insulin. This can lead to health problems including diabetes. Researchers have found that the drug metreleptin improves health in people with this disease. Objective: \- To test the safety a…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Double-Dye MRI could sharpen liver cancer detection
Diagnosis OngoingThis clinical trial studies contrast-enhanced magnetic resonance imaging (MRI) in detecting nonmalignant and malignant liver lesions. Diagnostic procedures, such as MRI, may help find and diagnose nonmalignant and malignant liver lesions. Contrast agents, such as gadoxetate disod…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Brain scans reveal how Weight-Loss drug targets appetite
Disease control OngoingThe purpose of this protocol is to investigate, using functional magnetic resonance imaging (fMRI), the effect of treatment with lorcaserin on centers of the brain that control appetite and food intake, as well as lorcaserin's downstream metabolic effects.
Phase 4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Breathing trick boosts walking after spinal injury
Symptom relief OngoingThe purpose of this study is to determine how the nervous system controlling leg muscles is altered following spinal cord injury and how they may be affected by brief periods of low oxygen inhalation over time. The investigators hypothesize: * Acute intermittent hypoxia (AIH) e…
Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Mesh vs. no mesh: which bladder prolapse surgery holds up better over time?
Disease control CompletedThe main purpose of this study is to evaluate the long-term (5-8 years) functional prolapse recurrence rate of the 147 patients enrolled, randomized and analyzed in the study PRO-CURE I.
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a simple drug cut blood loss in Kids' skull surgery?
Disease control OngoingThe purpose of this study is to determine whether Amicar (ε-aminocaproic acid) is effective in reducing blood loss in children undergoing craniofacial reconstruction surgery. The investigators hypothesize that Amicar will decrease intraoperative blood loss and decrease the need …
Phase 2 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can diet and exercise programs cut cancer risk? new study tests lifestyle changes
Prevention OngoingThis pilot clinical trial studies different types of energy balance interventions to see how well they work in increasing the physical activity levels of breast cancer gene-positive patients, Lynch syndrome-positive patients, chronic lymphocytic leukemia (CLL) survivors or family…
Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
New hope for dialysis patients with blocked chest veins
Disease control CompletedThe treatment objective for patients with SVC syndrome secondary to both malignant and benign etiologies is to reduce the elevated central venous pressures.1 However, the strategies are contingent upon the underlying disease process. Thus the management of SVC syndrome ranges fro…
Sponsor: Methodist Health System • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a cancer drug beat CLL fatigue? small trial hopes to find out
Symptom relief OngoingThis phase II trial studies how well ruxolitinib phosphate works in reducing fatigue in patients with chronic lymphocytic leukemia. Ruxolitinib phosphate may stop the growth of cancer cells by blocking a protein called Janus kinase (JAK) that is needed for cell growth and may als…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Could less radiation be safer for kids with neuroblastoma?
Disease control CompletedThe purpose of this study is to give 12T a smaller dose of radiation in order to decrease these late side effects.
Early phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Global krabbe disease registry aims to decode early warning signs
Knowledge-focused Recruiting nowThe purpose of this study is to develop a clinical database of individuals diagnosed with Krabbe disease in order to determine which symptoms herald the onset of clinical disease in the various phenotypes of Krabbe disease; to determine whether level of GALC enzyme activity, or a…
Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New drug combo shows promise for tough ovarian cancer
Disease control CompletedThe purpose of this study is to find out if a new drug, LDE225, is safe and has beneficial effects when combined with paclitaxel in women with platinum resistant ovarian cancer. Platinum resistant ovarian cancer refers to recurrent ovarian cancer that has undergone chemotherapy i…
Phase 1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New combo attack on liver cancer: drug activated by Tumor's own hypoxia
Disease control Recruiting nowThis phase 1 study is to determine the optimal dose and tolerability of a hypoxia-activating agent, tirapazamine, when it is combined with embolization in liver cancer. Liver cancer patients who are Child-Pugh score A, suitable for embolization with tumor no more than 4 nodules a…
Phase 1/2 • Sponsor: Teclison Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Massive study tests diabetes drug for heart attack recovery
Knowledge-focused OngoingThis observational, retrospective cohort study aims to evaluate the impact of sodium-glucose cotransporter 2 (SGLT2) inhibitor use after acute myocardial infarction (AMI) in patients with type 2 diabetes mellitus (T2DM). Using the nationwide database from the Korean National Heal…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Zap to see: electrical therapy for eye disease
Symptom relief OngoingMeasures of vision in RP patients receiving promising therapy using transcorneal electrical stimulation.
Sponsor: Nova Southeastern University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Scientists hunt for eye disease genes in 2,000-Person study
Knowledge-focused Recruiting nowObjective: The objective of this study is to identify genetic causes of inherited eye conditions through whole exome or whole genome sequencing (referred to as exome sequencing and genome sequencing in the remainder of the document). This includes identifying mutations in known g…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can a simple shot under the skin replace an IV for a key antibiotic in the elderly?
Knowledge-focused CompletedIn geriatric departments, physicians are faced with two difficulties, first the increasing number of infections caused by multiresistant bacteria, especially extended spectrum β-lactamase (ESBL) producing enterobacteria strains and second, the poor venous access frequently encoun…
Phase 4 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
New combo pill shows promise for diabetes control over one year
Disease control CompletedThe purpose of this study is to evaluate the safety and efficacy of co-administration of Teneligliptin (MP-513) and Canagliflozin (TA-7284) once daily for 52 weeks in Japanese patients with Type 2 diabetes mellitus who are receiving treatment with Teneligliptin and have inadequat…
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New radiation approach targets multiple tumors at once in early trial
Knowledge-focused CompletedThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or prostate cancer that has spread to other parts of the body. Stereotactic body radiation therapy delivers fe…
Phase 1 • Sponsor: NRG Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC